Subgaleal hemorrhage medical therapy

Jump to navigation Jump to search

Subgaleal Hemorrhage Microchapters

Home

Patient Information

Overview

Anatomy

Historical Perspective

Pathophysiology

Causes

Differentiating Subgaleal Hemorrhage from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Subgaleal hemorrhage medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Subgaleal hemorrhage medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Subgaleal hemorrhage medical therapy

CDC on Subgaleal hemorrhage medical therapy

Subgaleal hemorrhage medical therapy in the news

Blogs on Subgaleal hemorrhage medical therapy

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Subgaleal hemorrhage medical therapy

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Management consists of vigilant observation over days to detect progression. Fluid bolus may be required if blood loss is significant and patient becomes tachycardic. Transfusion and phototherapy may be necessary. Investigation for coagulopathy may be indicated.

References


Template:WikiDoc Sources